Adrenal insufficiency and Mobility decreased

Summary:

Mobility decreased is found among people with Adrenal insufficiency, especially for people who are female, 60+ old.

The study analyzes which people have Mobility decreased with Adrenal insufficiency. It is created by eHealthMe based on reports of 20 people who have Adrenal insufficiency from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Adrenal insufficiency?

Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids) is found to be associated with 965 drugs and 1,094 conditions by eHealthMe. Check the latest studies of Adrenal insufficiency.

What is Mobility decreased?

Mobility decreased (ability to move is reduced) is found to be associated with 1,775 drugs and 1,635 conditions by eHealthMe. Check the latest studies of Mobility decreased.

On Aug, 07, 2026

20 people who have Adrenal Insufficiency and Mobility Decreased are studied.

Would you have Mobility decreased when you have Adrenal insufficiency?

Gender of people who have Adrenal Insufficiency and experienced Mobility Decreased *:

female: 80 %
male: 20 %

Age of people who have Adrenal Insufficiency and experienced Mobility Decreased *:

Common co-existing conditions for these people *:

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 11 people, 55.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 30.00%
High Blood Cholesterol: 5 people, 25.00%
Thyroid Diseases: 5 people, 25.00%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 5 people, 25.00%
Depression: 5 people, 25.00%
Psoriasis (immune-mediated disease that affects the skin): 5 people, 25.00%
Torticollis (a twisted neck in which the head is tipped to one side, while the chin is turned to the other): 4 people, 20.00%
Bone Disorder: 4 people, 20.00%
Dry Eyes (lack of adequate tears): 4 people, 20.00%

Common drugs taken by these people *:

Xeljanz: 9 people, 45.00%
Humira: 8 people, 40.00%
Methotrexate: 7 people, 35.00%
Prednisone: 6 people, 30.00%
Hydroxychloroquine Sulfate: 5 people, 25.00%
Triamcinolone Acetonide: 5 people, 25.00%
Orencia: 5 people, 25.00%
Folic Acid: 5 people, 25.00%
Cimzia: 5 people, 25.00%
Remicade: 5 people, 25.00%

Common symptoms for these people *:

Malaise (a feeling of general discomfort or uneasiness): 10 people, 50.00%
Pain: 8 people, 40.00%
Nausea And Vomiting: 8 people, 40.00%
Fall: 7 people, 35.00%
Weakness: 7 people, 35.00%
Immunodeficiency: 6 people, 30.00%
Hypotension (abnormally low blood pressure): 6 people, 30.00%
High Blood Pressure: 6 people, 30.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 30.00%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 6 people, 30.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Mobility decreased?

- Check whether Mobility decreased is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Adrenal insufficiency (16,569 reports)
Mobility decreased (83,538 reports)

All the drugs that are associated with Mobility decreased:

Mobility decreased (1,775 drugs)

All the conditions that are associated with Mobility decreased:

Mobility decreased (1,635 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Mobility decreased and Adrenal insufficiency, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.